Page last updated: 2024-08-24

topotecan and lbw242

topotecan has been researched along with lbw242 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Accarpio, F; Benedetti-Panici, P; Bernabei, M; Biffoni, M; Casorelli, A; Di Donato, V; Di Giorgio, A; Pasquini, L; Petrucci, E; Saulle, E; Sibio, S; Testa, U	1

Other Studies

1 other study(ies) available for topotecan and lbw242

Article	Year
A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells. PloS one, 2012, Volume: 7, Issue:4 Topics: Analysis of Variance; Annexin A5; Antineoplastic Agents; Blotting, Western; Cell Death; Cell Line, Tumor; Drug Synergism; Female; Flow Cytometry; Humans; In Vitro Techniques; Oligopeptides; Ovarian Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Topotecan; Transduction, Genetic	2012

Article

Year

A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells.

PloS one, 2012, Volume: 7, Issue:4

Topics: Analysis of Variance; Annexin A5; Antineoplastic Agents; Blotting, Western; Cell Death; Cell Line, Tumor; Drug Synergism; Female; Flow Cytometry; Humans; In Vitro Techniques; Oligopeptides; Ovarian Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Topotecan; Transduction, Genetic

2012